Todd Tushla Thank you and happy Cinco de Mayo to everyone. Welcome to Neurocrine Biosciences 1st quarter 2026 earnings call. Joining me today are Kyle Gano, Chief Executive Officer, Matthew Abernethy, Chief Financial Officer, Eric Benevich, Chief Commercial Officer, Sanjay Keswani, Chief Medical Officer, and Samir Siddhanti, Vice President of Strategy and Corporate Development. During today's call, we will be making forward-looking statements, including statements containing projections regarding future eve ...